Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade F 17.335 -1.84% -0.33
BHC closed down 0.34 percent on Tuesday, August 11, 2020, on 1.69 times normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BHC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -1.84%
50 DMA Resistance Bearish -1.84%
MACD Bearish Signal Line Cross Bearish -1.84%
Calm After Storm Range Contraction -1.84%
Stochastic Reached Oversold Weakness -1.84%
Outside Day Range Expansion -1.84%
Down 3 Days in a Row Weakness -1.84%
Oversold Stochastic Weakness -1.84%
20 DMA Resistance Bearish -2.17%
50 DMA Resistance Bearish -2.17%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Biotechnology Life Sciences Organ Systems Laser S&P/Tsx 60 Index Psoriasis Specialty Drugs Medical Devices Ulcerative Colitis Atopic Dermatitis Acne Diarrhea Irritable Bowel Syndrome Hair Removal Generic Pharmaceuticals Salix Pharmaceuticals Eye Health Products Over The Counter Products

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.97
52 Week Low 11.15
Average Volume 4,389,233
200-Day Moving Average 22.10
50-Day Moving Average 18.50
20-Day Moving Average 18.30
10-Day Moving Average 18.73
Average True Range 1.06
ADX 17.28
+DI 34.73
-DI 25.08
Chandelier Exit (Long, 3 ATRs ) 19.80
Chandelier Exit (Short, 3 ATRs ) 19.96
Upper Bollinger Band 19.90
Lower Bollinger Band 16.71
Percent B (%b) 0.3
BandWidth 17.44
MACD Line 0.06
MACD Signal Line 0.11
MACD Histogram -0.0498
Fundamentals Value
Market Cap 6.16 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -5.40
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.37
Resistance 3 (R3) 19.54 19.13 19.09
Resistance 2 (R2) 19.13 18.70 19.05 18.99
Resistance 1 (R1) 18.40 18.43 18.20 18.23 18.89
Pivot Point 17.99 17.99 17.89 17.91 17.99
Support 1 (S1) 17.26 17.56 17.06 17.09 16.43
Support 2 (S2) 16.85 17.29 16.77 16.33
Support 3 (S3) 16.12 16.85 16.24
Support 4 (S4) 15.95